glp-1 drugs key developments 2025 Market Overview: Agonists and the Obesity Market | Blog GLP-1 Market Trends and Global
Description
"About 1 in 8 adult Americans has already used GLP-1 drugs
Thus, early treatment of NASH with GLP-1 RAs may be more effective
GLP-1 increases insulin and decreases glucagon levels, which will result in decreased blood glucose [8, 9]
The best factors to look at are effectiveness, frequency of dosing and side effect profiles
The novel GLP-1 receptor agonist (Ex-4)2-Fc, developed by Zhou et al., demonstrated anti-inflammatory activity in their study
When calorie and protein intake are significantly reduced, the body may break down muscle tissue for energy
